UA40574C2 - Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки - Google Patents

Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки

Info

Publication number
UA40574C2
UA40574C2 UA94005054A UA94005054A UA40574C2 UA 40574 C2 UA40574 C2 UA 40574C2 UA 94005054 A UA94005054 A UA 94005054A UA 94005054 A UA94005054 A UA 94005054A UA 40574 C2 UA40574 C2 UA 40574C2
Authority
UA
Ukraine
Prior art keywords
derivatives
obtaining
cortisone
oxo
radical
Prior art date
Application number
UA94005054A
Other languages
English (en)
Russian (ru)
Inventor
Бюандіа Жан
Бюандиа Жан
Шовен Ремі
Шовен Реми
Віва Мішель
Вива Мишель
Original Assignee
Хьохст Маріон Руссель
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хьохст Маріон Руссель, Хехст Марион Руссель filed Critical Хьохст Маріон Руссель
Publication of UA40574C2 publication Critical patent/UA40574C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Epoxy Resins (AREA)

Abstract

Винхід належить до нових похідних 17,20 - епоксидів прегнану, їх отримання, їх застосування для отримання кортизонних похідних і проміжних сполук. Похідні 17,20 -поксипрегнану формули (I): де R - радикал оксо або ß-гідроксі и цикли А і В означають залишок формули: де К - радикал оксо або група, що захищає радикал оксо, формули: n дорівнює 2 або 3 і R1 - залишок ефіру або складного ефіру, К' - радикал оксо або захисна група типу оксиму, гідразону або семікарбазону, і хвилясті лінії означають суміш ізомерів.
UA94005054A 1993-01-14 1994-01-12 Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки UA40574C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300290A FR2700339B1 (fr) 1993-01-14 1993-01-14 Nouveaux dérivés 17,20-époxydes du pregnane, leur préparation, leur application à la préparation de dérivés cortisoniques et intermédiaires.

Publications (1)

Publication Number Publication Date
UA40574C2 true UA40574C2 (uk) 2001-08-15

Family

ID=9443017

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94005054A UA40574C2 (uk) 1993-01-14 1994-01-12 Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки

Country Status (18)

Country Link
US (2) US5504203A (uk)
EP (1) EP0607088B1 (uk)
JP (1) JP3356525B2 (uk)
KR (1) KR100312268B1 (uk)
CN (2) CN1057304C (uk)
AT (1) ATE151435T1 (uk)
AU (1) AU667413B2 (uk)
CA (1) CA2113404C (uk)
DE (1) DE69402441T2 (uk)
DK (1) DK0607088T3 (uk)
ES (1) ES2100023T3 (uk)
FR (1) FR2700339B1 (uk)
GR (1) GR3023106T3 (uk)
HU (1) HU217632B (uk)
PL (1) PL181805B1 (uk)
RU (1) RU2125060C1 (uk)
UA (1) UA40574C2 (uk)
YU (1) YU49025B (uk)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724174B1 (fr) * 1994-09-06 1997-01-17 Roussel Uclaf Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
JP5564517B2 (ja) 2009-02-20 2014-07-30 ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ グルタチオンをベースとする薬物送達システム
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US9554418B1 (en) 2013-02-28 2017-01-24 F5 Networks, Inc. Device for topology hiding of a visited network
CN107663171A (zh) * 2017-10-10 2018-02-06 常州市阳光药业有限公司 高纯度托伐普坦的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2123217A (en) * 1937-07-15 1938-07-12 Merck & Co Inc Process for the production of hormones
US2541439A (en) * 1949-02-18 1951-02-13 Merck & Co Inc Osmate esters of 20-cyanopregnanes and process
US2648688A (en) * 1950-12-23 1953-08-11 Merck & Co Inc Process for peparing 21-alkyl ethers of cortisone
US2813860A (en) * 1954-12-31 1957-11-19 Upjohn Co Steroids
US2744108A (en) * 1955-01-13 1956-05-01 Searle & Co 3-ethylene mercaptoles of 11-oxygenated derivatives of 17, 21-dihydroxy-4-pregnene-3, 20-diones
US2912446A (en) * 1955-01-14 1959-11-10 Merck & Co Inc delta1, 4-3, 20-diketo-11-oxygenated-17alpha-hydroxy-pregnadienes and 9-fluoro derivatives thereof
US2844600A (en) * 1955-10-10 1958-07-22 Upjohn Co 22-cyanohydrins of bis-nor cholen-al compounds
US3285940A (en) * 1959-06-04 1966-11-15 Merck & Co Inc 16-methyl-delta-1, 4, 16-pregnatriene-3, 20-dione compounds
US3118882A (en) * 1961-02-16 1964-01-21 American Home Prod Preparation of 17alpha-fluoroprogesterone and intermediates therein
US3074979A (en) * 1961-05-08 1963-01-22 Merck & Co Inc 3-mono-oxime derivatives of c-4 unsaturated steroids
US3419582A (en) * 1965-08-23 1968-12-31 Warner Lambert Pharmaceutical Pentacyclic steroids and process
US3378574A (en) * 1966-03-30 1968-04-16 Merck & Co Inc Process of hydrolyzing 16beta-alkyl-16alpha, 17alpha-oxido-11, 20 bis-oxygenated-1, 4-pregnadiene-3, 20-diones
DE2330581A1 (de) * 1973-06-15 1975-01-16 Warner Lambert Co Steroidyloestratriene, ihre verwendung und verfahren zur herstellung derselben
DE2336438C2 (de) * 1973-07-14 1983-07-07 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 17 β- Oxalylsteroiden
HU171166B (hu) * 1975-07-15 1977-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh ehpoksi-androstanov
FR2423486A1 (fr) * 1978-04-19 1979-11-16 Roussel Uclaf Nouveau reactif d'epoxydation
US4600538A (en) * 1984-08-02 1986-07-15 The Upjohn Company Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes
FR2676740B1 (fr) * 1991-05-23 1993-11-05 Roussel Uclaf Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires.
FR2691968B1 (fr) * 1992-06-04 1994-07-29 Roussel Uclaf Nouveau procede de preparation d'un derive sterouide 11-ceto.

Also Published As

Publication number Publication date
JPH06279486A (ja) 1994-10-04
YU49025B (sh) 2003-07-07
HUT67551A (en) 1995-04-28
HU217632B (hu) 2000-03-28
EP0607088B1 (fr) 1997-04-09
CN1057304C (zh) 2000-10-11
DE69402441D1 (de) 1997-05-15
EP0607088A1 (fr) 1994-07-20
YU82293A (sh) 1996-07-24
HU9400094D0 (en) 1994-05-30
CA2113404C (fr) 2004-10-19
AU5316194A (en) 1994-07-21
JP3356525B2 (ja) 2002-12-16
ATE151435T1 (de) 1997-04-15
DE69402441T2 (de) 1997-10-30
DK0607088T3 (da) 1997-10-06
RU2125060C1 (ru) 1999-01-20
CN1095847C (zh) 2002-12-11
AU667413B2 (en) 1996-03-21
CN1096790A (zh) 1994-12-28
GR3023106T3 (en) 1997-07-30
PL301862A1 (en) 1994-07-25
PL181805B1 (pl) 2001-09-28
US5504203A (en) 1996-04-02
KR100312268B1 (ko) 2002-06-20
FR2700339A1 (fr) 1994-07-13
CA2113404A1 (fr) 1994-07-15
KR940018395A (ko) 1994-08-16
CN1182092A (zh) 1998-05-20
ES2100023T3 (es) 1997-06-01
FR2700339B1 (fr) 1995-03-03
US5892028A (en) 1999-04-06

Similar Documents

Publication Publication Date Title
MY113806A (en) Antiparasitic marcfortines and paraherquamides
AUPP268898A0 (en) High modulus polyurethane compositions
WO1992002534A3 (en) Compounds and methods for inhibiting gene expression
BG103485A (en) Ketobanzamides as calpain inhibitors
WO1987004426A3 (fr) Compositions de vinyle
IT1271325B (it) Composti diastereomericamente puri derivati da 3-oxo e 3-tioxo-4-azaandrostani e loro uso come antiandrogeni
CA2080249A1 (en) Preparation of substituted piperidines
UA40574C2 (uk) Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки
AU544923B2 (en) Peptides
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
AU8124494A (en) Conversion of bisnoralcohol to bisnoraldehyde
AU1343388A (en) Iodinated polymers
DE69403541D1 (de) Lacton-Verbindung und Verfahren zu ihrer Herstellung
TW427997B (en) New preparation process for a 16 β-methyl steroid and new intermediates
NO924786D0 (no) Polyolefinmaterialer podet med en epoksyalkylakrylat-forbindelse
ES8701737A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ZA941533B (en) Hydroxymethylfurazancarboxylic acid derivatives
UA41871C2 (uk) Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі
ES8400416A1 (es) Procedimiento para la fabricacion de acil-2 hexahidro-1,3,4,6,7,11b-2h-piracino (2,1-a) isoquinoleinonas-4 e intermediarios.
UA35556C2 (uk) Спосіб одержання гідрокортизону та проміжні сполуки в синтезі гідрокортизону
AU648285B2 (en) Coating material, process for producing it and its use
WO1998049998A3 (de) Verwendung von glykosidischen siliconverbindungen zur herstellung von kosmetischen und/oder pharmazeutischen zubereitungen
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
MX9801130A (es) Tiamacrolidos.
ES8405033A1 (es) Procedimiento para la obtencion de esteroides dihalogenados.